StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s): SZLSF

Healthcare Biotechnology

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is engaged in improving the early detection and management of cancer and other chronic diseases through diagnostics and telehealth programs that provide clinical interventions to assist patients who have cancer (COC Protocol), and help patients reduce the risk of developing late-stage disease (AVRT). Its test, Aristotle, is the first mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high sensitivity and specificity for each cancer. Aristotle uses mRNA technology to identify the molecular signatures of multiple cancer types and is built on the Company's patented technology platform, the Sentinel Principle. The Care Oncology Clinic offers a supervised treatment regimen (the COC Protocol) for people diagnosed with cancer of any type or stage. Its ColonSentry is a proprietary blood test for screening for Colorectal Cancer.

TSX:SZLS - Post by User

StageZero Life Sciences Ltd > Lumina,Grail

<< Previous

Bullboard Posts

Next >>

Comment by capebretongirlon Jul 15, 2021 2:54pm

164 Views

Post# 33553416

RE:RE:RE:RE:RE:RE:RE:RE:Lumina,Grail

Thanks Dave - I am referring to SZLS.WT warrants and indeed it is unclear.

Certainly in the event of a takeover if common shares were purchased for example at a double today in a friendly takeover scenario (ie: .84 cents ) and SZLS.WT were given a value of .025 (today) instead of .05 cents - then the message would be to buy common shares instead of warrants - strictly from a takeover perspective..

davewho wrote: I found this comment on reddit. Can't vouch for the accuracy though.

The answer is that it depends.

You should read the term of your warrant. I assume you are holding a warrant in a Canadian public company? If so, the warrant indenture was filed on SEDAR when the warrant offering originally closed. This will set out what happens on a change of control of the company.

If the acquisition of the company requires a shareholder vote, the proxy circular that is sent to shareholders to describe the transaction and to solicit the vote will describe what is happening to warrants. For example, in a plan of arrangement in Canada, the holder may be entitled to a cash payment for the in-the-money value (without any need to exercise) or the holder may just be getting a replacement warrant (with necessary adjustments to reflect the consideration under the deal).